(2R,3R)-2,3-Dihydroxysuccinic acid - (9α,13α,14α)-17-methylmorphinan-3-ol (1:1);Levorphanol tartrate;1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol tartrate,d;d-1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol Tartrate;Dextrorphan Tartrate Salt;17-Methyl-morphinan-3-ol,Lg-Hydrogentartrat;d-3-Hydroxy-N-methylmorphinan tartrate;Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with (9α,13α,14α)-17-methylmorphinan-3-ol (1:1);17-methyl-morphinan-3-ol,Lg-hydrogentartrate;MFCD00151495;(+)-(9a,13a,14a)-17-methylmorphinan-3-ol Tartrate (1:1) (Salt);Dextrophan tartrate
−70℃
H2O: >10mg/mL
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:5 3.氢键受体数量:8 4.可旋转化学键数量:3 5.互变异构体数量:3 6.拓扑分子极性表面积139 7.重原子数量:29 8.表面电荷:0 9.复杂度:491 10.同位素原子数量:0 11.确定原子立构中心数量:5 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2